Clinical Trial Update: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

View source ↗

Summary

A clinical trial update describes emergency use of adoptive CMV-specific T cell therapy following donor bone marrow transplant in an infant with immunodeficienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Immunodeficiency

Drugs mentioned

• CMV-specific T cells (adoptive immunotherapy) (CMV-specific T cells)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Infection, Precancerous/Nonmalignant Condition | Status: NO_LONGER_AVAILABLE